Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Blair, Emilie M.a | Reale, Bailey K.a; b | Zahuranec, Darin B.c | Forman, Janea; d | Langa, Kenneth M.a; d; e; f | Giordani, Brunog | Fagerlin, Angelah | Kollman, Colleeni | Whitney, Rachael T.a | Levine, Deborah A.a; b; e; *
Affiliations: [a] Department of Internal Medicine and Cognitive Health Services Research Program, University of Michigan (U-M), Ann Arbor, MI, USA | [b] Lake Erie College of Osteopathic Medicine, Greensburg, PA, USA | [c] Department of Neurology and Stroke Program, U-M, Ann Arbor, MI, USA | [d] VA Ann Arbor Healthcare System, Ann Arbor, MI, USA | [e] Institute for Healthcare Policy and Innovation, U-M, Ann Arbor, MI, USA | [f] Institute for Social Research, U-M, Ann Arbor, MI, USA | [g] Department of Psychiatry & Michigan Alzheimer’s Disease Center, U-M, Ann Arbor, MI, USA | [h] Department of Population Health Sciences, UT and Salt Lake City VA Informatics Decision-Enhancement and Analytic Sciences (IDEAS 2.0) Center for Innovation, University of Utah, Salt Lake City, UT | [i] Kollman Research Services, Ann Arbor, MI, USA
Correspondence: [*] Correspondence to: Deborah A. Levine, MD, MPH, University of Michigan Division of General Medicine, North Campus Research Complex, 2800 Plymouth Rd, B16-F4, Ann Arbor, MI 48109-2800, USA. Tel.: +1 734 936 5216; E-mail: deblevin@umich.edu.
Abstract: Background:People with mild cognitive impairment (MCI) receive fewer guideline-concordant treatments for cardiovascular disease (CVD) than people with normal cognition (NC). Objective:To understand physician perspectives on why patients with MCI receive fewer CVD treatments than patients with NC. Methods:As part of a mixed-methods study assessing how patient MCI influences physicians’ decision making for acute myocardial infarction (AMI) and stroke treatments, we conducted a qualitative study using interviews of physicians. Topics included participants’ reactions to data that physicians recommend fewer CVD treatments to patients with MCI and reasons why participants think fewer CVD treatments may be recommended to this patient population. Results:Participants included 22 physicians (8 cardiologists, 7 neurologists, and 7 primary care physicians). Most found undertreatment of CVD in patients with MCI unreasonable, while some participants thought it could be considered reasonable. Participants postulated that other physicians might hold beliefs that could be reasons for undertreating CVD in patients with MCI. These beliefs fell into four main categories: 1) patients with MCI have worse prognoses than NC, 2) patients with MCI are at higher risk of treatment complications, 3) patients’ cognitive impairment might hinder their ability to consent or adhere to treatment, and 4) patients with MCI benefit less from treatments than NC. Conclusion:These findings suggest that most physicians do not think it is reasonable to recommend less CVD treatment to patients with MCI than to patients with NC. Improving physician understanding of MCI might help diminish disparities in CVD treatment among patients with MCI.
Keywords: Aging, cognition, treatment disparities
DOI: 10.3233/JAD-220495
Journal: Journal of Alzheimer's Disease, vol. 91, no. 2, pp. 573-584, 2023
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl